Global Coalition on Aging Experts Headline First World Congress on Healthy Ageing

Coalition Brings Business Perspective to Global Aging Dialogue

KUALA LUMPUR, MALAYSIA (Mar. 19, 2012) – The Global Coalition on Aging will lead two plenary sessions during the First World Congress on Healthy Ageing, calling for business, government, NGOs, communities, and individuals to take action toward increasing personal well being, productivity and economic growth as societies are aging at unprecedented rates. The Global Coalition is a main supporter of the congress, which takes place March 19-22 in Kuala Lumpur, Malaysia.

“The creation of good health policy today in light of 21st-century aging trends is essential economic policy for tomorrow, as nations must prepare for the imminent onslaught of non-communicable diseases (NCDs), like diabetes, cancers, cardiovascular disease and Alzheimer’s, which are rapidly increasing in terms of prevalence and costs as we age,” said Coalition Executive Director Michael Hodin. “This congress is especially timely as the EU celebrates its Year of Healthy and Active Aging and the World Health Organization focuses World Health Day 2012 on aging and health. The Global Coalition on Aging applauds the Malaysian Healthy Ageing Society and the WHO for organizing this groundbreaking event, which will lead the way toward identifying the policies and partnerships that will bring about real change across the Asia-Pacific and the globe.”

Population aging – a combination of longer life and a decrease in birth rates – is leading to a shift in the size and proportion of those traditionally viewed as “old” compared to “young.” To address this shift, the Global Coalition envisions nothing short of defining a new middle age – 55 to 75 – around which policy and markets will enable an active and healthier life that transforms this demographic cohort from being dependent to becoming economic contributors.

The congress will welcome more than 1,000 leaders and innovators from across health care, government, business, and academia. The two sessions presented by the Global Coalition are:

  1. March 20: “Investment in Health as Economic Policy for 21st-Century Active Aging” will focus on how economic policy and health policy are inextricably linked, bringing particular focus on non-communicable diseases (NCDs) as cost drivers that demand a call for action, and
  2. March 22: “New Approaches to Healthy Ageing from Across the Globe” will present examples from the region and from global business to highlight how innovation and collaborative efforts are critical in changing the mindset and taking action to turn population aging into opportunity.

“We welcome the Global Coalition’s business perspective to the congress and the Asia-Pacific region, in which we have both developed and developing nations seeing incredible growth in the 60-plus population over the next few decades,” said Assoc. Prof. Nathan Vytialingam, President of the Malaysian Healthy Ageing Society and Organising Chairman of the 2012 Congress.  According to the United Nations Economic and Social Commission for Asia and the Pacific, 62 percent of the world’s 60-plus population, or 1.2 billion people, will live in Asia in 2050. “In our region and globally, we pledge to work with the Coalition and other like-minded partners within business, government, NGOs, and other innovators to find solutions that promote healthy aging and opportunities for growth.”

Experts headlining the Coalition plenary sessions include:

  • John Beard, Director of the Department of Ageing and Life Course, World Health Organization (Switzerland)
  • Dan Brindle, Senior Director, International Public Affairs & Policy (Asia), Pfizer (China)
  • Antonio Dans, President, Philippine Society of General Internal Medicine; Professor, University of the Philippines College of Medicine, Department of Medicine, UP College of Medicine (Philippines)
  • William Green, Director of Public Affairs and Relations, Nutricia Advanced Medical Nutrition (The Netherlands)
  • Prof. Anindya Mishra, Assistant Professor, Department of Humanities and Social Sciences, Indian Institute Technology, Roorkee (India)
  • Melissa Mitchell, Deputy Director, Global Coalition on Aging (United States)
  • Gregor Rae, Chairman and CEO, BusinessLab and ActiveAge (United Kingdom)

Latest Developments

We keep our members and partners in touch with the most recent updates and opinions in the worldwide dialogue on population longevity and related issues.

What Old Age Might Be Like for Today’s 30-Year-Olds

Get ready for a new old age. With the U.S. fertility rate in a decadelong slump and the life expectancy of 65-year-old Americans approaching roughly 85, our aging nation is likely to grow older by midcentury, as the ratio of young to old continues to decline. The trend is likely to upend how our society is organized, making life very different for today’s 30-year-olds when they reach their 60s compared with life for 60-year-olds now.

World Population Reaches 8bn As It Grows Older

The world’s population reached 8bn people on Tuesday and will hit 9bn in 15 years as it experiences an unprecedented surge in the number of older people, according to the latest UN data. The global fertility rate has more than halved since the 1950s to 2.3 births per woman. With mortality also falling, the number of people aged 65 and over is expected to rise from 783mn in 2022 to 1bn by 2030 and reach 1.4bn by 2043, the UN population data revealed.

Global Coalition on Aging (GCOA) Launches Cross-Sector Alliance Committed to Health Innovation at High-Level Forum on The Silver Economy

Today, the Global Coalition on Aging (GCOA), along with cross-sector stakeholders representing patient advocacy, policy, industry, and academic communities, announced the launch of the Alliance for Health Innovation at the High-Level Forum on the Silver Economy in New York. The Alliance is dedicated to establishing the importance of innovation in achieving healthy aging and health equity through investments, policy reforms, and strategic partnerships.

Japan Must Face Up to Growing Danger of Drug-resistant Germs

In the wake of more than 6.4 million COVID-19 deaths worldwide and unprecedented economic destruction, the global community has no excuse to be caught unprepared for the next pandemic. Yet right now, a devastating parallel plague is already underway and worsening. Some years, it is killing well over 1 million people, according to medical journal The Lancet.

A Bipartisan Bill Could Prevent The Next Pandemic

In Washington, Republicans and Democrats are typically at loggerheads when it comes to healthcare policy. Just consider the recent Inflation Reduction Act, which made extensive changes to Medicare and also extended Affordable Care Act subsidies. Every single congressional Democrat voted for the legislation, while every single member of the GOP voted against it. But occasionally, a bill is such an obviously good idea, and so desperately needed, that it commands significant bipartisan support. The PASTEUR Act, co-sponsored by 31 Democrats and 31 Republicans in the House and two members of each party in the Senate, is just such a bill.

Korea Must Act Now to Combat Growing AMR Threat

Public officials are overlooking one of the gravest long-term threats to the Korean people, the health system, and economy: antimicrobial resistance (AMR). Some pathogens ― bacteria, fungi, parasites, and viruses ― have evolved strains that resist the antimicrobial medications we currently have available to fight them. Health care professionals often must watch helplessly as patients succumb to infections that antibiotics could once have easily beaten. They know that new antimicrobials, including and especially antibiotics, could easily gain the victory ― but they have none at their disposal.

Policy Statement on the Impact of Price Negotiations on Innovation, Healthy Aging and Equity

As the CEO of the Global Coalition on Aging (GCOA) and a newly formed cross-sector Alliance for Health Innovation, we write to express our deep concern with the current legislation that allows for price “negotiations” in Medicare – a thinly veiled signal for America’s plunge into price controls that will have a devastating and adverse impact on biopharmaceutical innovation and our nations’ ability to support healthy aging.